Article
FDA's Proposal For Naming Biosimilars Pleases Some, Disappoints Others
The Biologics Price Competition and Innovation Act of 2009 (BPCIA) created an abbreviated pathway for the approval of biosimilar biological products, but is silent on how to name them.
Patterson Belknap Webb & Tyler LLP
